Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/10256/9175

Safety of intramuscular influenza vaccine in patients receiving oral anticoagulation therapy: a single blinded multi-centre randomized controlled clinical trial
Casajoana, Josep; Iglesias, Begoña; Fàbregas, Mireia; Fina, Francesc; Vallès, Joan-Antoni; Aragonès, Rosa; Benítez, Mència; Zabaleta del Olmo, Edurne
Influenza vaccines are recommended for administration by the intramuscular route. However, many physicians use the subcutaneous route for patients receiving an oral anticoagulant because this route is thought to induce fewer hemorrhagic side effects. Our aim is to assess the safety of intramuscular administration of influenza vaccine in patients on oral anticoagulation therapy. Methods: Design: Randomised, controlled, single blinded, multi-centre clinical trial. Setting: 4 primary care practices in Barcelona, Spain. Participants: 229 patients on oral anticoagulation therapy eligible for influenza vaccine during the 2003
2004 season. Interventions: intramuscular administration of influença vaccine in the experimental group (129 patients) compared to subcutaneous administration in the control group (100 patients). Primary outcome: change in the circumference of the arm at the site of injection at 24 hours. Secondary outcomes: appearance of local reactions and pain at 24 hours and at 10 days; change in INR (International Normalized Ratio) at 24 hours and at 10 days. Analysis was by intention to treat using the 95% confidence intervals of the proportions or mean differences. Results: Baseline variables in the two groups were similar. No major side effects or major haemorrhage during the follow-up period were reported. No significant differences were observed in the primary outcome between the two groups. The appearance of local adverse reactions was more frequent in the subcutaneous administration group (37,4% vs. 17,4%, 95% confidence interval of the difference 8,2% to 31,8%). Conclusion: This study shows that the intramuscular administration route of influenza vaccine in patients on anticoagulant therapy does not have more side effects than the subcutaneous administration route
04-06-2014
Anticoagulants (Medicina)
Anticoagulants (Medicine)
Anticoagulantes
Injeccions intramusculars
Injections, Intramuscular
Reconeixement 3.0 Espanya
http://creativecommons.org/licenses/by/3.0/es/deed.ca
Artículo
info:eu-repo/semantics/publishedVersion
Biomed Central Publishers
         

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

García Gil, María del Mar; Hermosilla, Eduardo; Prieto Alhambra, Daniel; Fina, Francesc; Rosell, Magdalena; Ramos Blanes, Rafel; Rodriguez, Jordi; Williams, Tim; Van Staa, Tjeerd; Bolíbar, Bonaventura
García Gil, María del Mar; Hermosilla, Eduardo; Prieto Alhambra, Daniel; Fina, Francesc; Rosell, Magdalena; Ramos Blanes, Rafel; Rodriguez, Jordi; Williams, Tim; Van Staa, Tjeerd; Bolíbar, Bonaventura
Foguet Boreu, Quintí; Fernandez San Martin, Maria Isabel; Flores Mateo, Gemma; Zabaleta del Olmo, Edurne; Ayerbe García-Morzon, Luis; Perez-Piñar López, Maria; Martin López, Luis Miguel; Montes Hidalgo, Javier; Violán, Concepción